What's new in the treatment of neonatal shock

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 24, Issue SUPPL. 1, 2011, Pages 17-19

  Caresta, Elena ^a   Papoff, Paola ^a   Benedetti Valentini, Sara ^a   Mancuso, Michele ^a   Cicchetti, Roberto ^a   Midulla, Fabio ^a   Moretti, Corrado ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Neonatal shock; Sepsis; Treatment

Indexed keywords

ADRENALIN; CATECHOLAMINE; DOBUTAMINE; DOPAMINE; INOTROPIC AGENT; LEVOSIMENDAN; MILRINONE; TERLIPRESSIN; VASOPRESSIN; HYPERTENSIVE FACTOR; INODILATOR AGENT; UNCLASSIFIED DRUG; VASOACTIVE AGENT; VASODILATOR AGENT;

DRUG MECHANISM; FLUID THERAPY; HEMODYNAMICS; HUMAN; NEONATAL SEPTIC SHOCK; NEWBORN; NEWBORN INTENSIVE CARE; PATENT DUCTUS ARTERIOSUS; PEDIATRIC SEPTIC SHOCK; PEDIATRICS; PERSISTENT PULMONARY HYPERTENSION; PRIORITY JOURNAL; REVIEW; SEPTIC SHOCK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; NEWBORN DISEASE;

HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; INTENSIVE CARE UNITS, NEONATAL; NEONATOLOGY; SHOCK; SHOCK, SEPTIC;

EID: 80053291890     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2011.607565     Document Type: Review

References (10)

1. Wynn JL, Wong HR. Pathophysiology and treatment of septic shock in neonates. Clin Perinatol 2010;37:439-479.
2. Goldstein B, Giroir B, Randolph A; International Consensus Conference on Pediatric Sepsis. International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 2005;6:2-8.
3. Ceneviva G, Paschall JA, Maffei F, Carcillo JA. Hemodynamic Support in Fluid-refractory Pediatric Septic Shock. Pediatrics 1998; 102:19.
4. Brierley J, Carcillo JA, Choong K et al. Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. Crit Care Med 2009;37:666-688.
5. Giliberti P, Giordano L, Chello G, De Leonibus C, Giliberti P. The scenarios of shock in newborn infants. J Matern Fetal Neonatal Med 2010;23:27-29.
6. Tourneux P, Rakza T, Abazine A, Krim G, Storme L. Noradrenaline for management of septic shock refractory to fluid loading and dopamine or dobutamine in full-term newborn infants. Acta Paediatr 2008;97:177-180. (Pubitemid 351197955)
7. Barton P, Garcia J, Kouatli A, Kitchen L, Zorka A, Lindsay C, Lawless S, Giroir B.Hemodynamic effects of i.v. milrinone lactate in pediatric patients with septic shock. A prospective, doubleblinded, randomized, placebo-controlled, interventional study. Chest 1996;109:1302-1312. (Pubitemid 26145670)
8. De Luca L, Colucci WS, Nieminen MS, Massie BM, Gheorghiade M. Evidence-based use of levosimendan in different clinical settings. European Heart J 2006;27:1908-1920. (Pubitemid 44297362)
9. Lechner E, Moosbauer W, Pinter M, Mair R, Tulzer G. Use of levosimendan, a new inodilator, for postoperative myocardial stunning in a premature neonate. Pediatr Crit Care Med 2007;8:61-63. (Pubitemid 46168361)
10. Leone M, Martin C. Role of terlipressin in the treatment of infants and neonates with cathecolamine-resistant septic shock. Best Pract Res Clin Anaesthesiol 2008;22:323-33. (Pubitemid 351804047)